Joel Greenblatt acquired 15.1 Thousand Jazz Pharmaceuticals plc shares worth $1.49 Million. That's 0.02% of their equity portfolio (740th largest holding). The first Jazz Pharmaceuticals plc trade was made in Q1 2014. Since then Joel Greenblatt bought shares seventeen more times and sold shares on twenty occasions. The investor's estimated purchase price is $2.01 Million, resulting in a loss of 26%.